Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005389 |
ID: | TCMBANKHE005389 |
植物拉丁名: |
|
功能与主治: | See Murraya paniculata./See Murraya paniculata. |
药用植物名: | 小叶九里香 |
药用部位: | leaf and branchlet |
TCM_ID_id: | 5293 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000088 | cryptotanshinone | NCI60_031208; CTS; 4733-35-1; A822990; C19H22O3; ZINC02109876; SMR000387041; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g][1]benzoxole-10,11-dione; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-quinone; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g]benzofuran-10,11-dione; NCGC00163650-01; BB_NC-1574; Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-; MolPort-006-823-903; (1R)-1,6,6-trimethyl-1,2,3a,6,7,8,9,11a-octahydrophenanthro[1,2-b]furan-10,11-dione; MLS001049002; 35825-57-1; DTXSID0044072; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-dione; (-)-Cryptotanshinone; Phenanthro(1,2-b)furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-; SPECTRUM1505812 | C19H20O3 | 296.36 | CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C |
| TCMBANKIN000114 | theophylline | C7H8N4O2 | 180.16 g/mol | CN1C2=C(C(=O)N(C1=O)C)NC=N2 | |
| TCMBANKIN000961 | Murrangatin-1-methyl ether | ||||
| TCMBANKIN002741 | meranzin hydrate | meranzinhydrate | C15H18O5 | 278.3 | CC(C)(C(CC1=C(C=CC2=C1OC(=O)C=C2)OC)O)O |
| TCMBANKIN004903 | 7-methoxy-4'-hydroxyflavone | C16H12O4 | 268.26 g/mol | COC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=C(C=C3)O | |
| TCMBANKIN004976 | 1.3.8- to- Mint triene | ||||
| TCMBANKIN006026 | Iso-horn-ene | ||||
| TCMBANKIN006723 | ostho | ||||
| TCMBANKIN007292 | (1R)-2,6,6- trimethyl [3.1.1] hept-2-ene | ||||
| TCMBANKIN007530 | Pakistan may ene | ||||
| TCMBANKIN007590 | 1-(7-methoxy-2-oxo-2H-chromen-8-yl)-3-methyl-1-oxobutan-2-yl-acetate | C12H10O4 | COC1=C(C2=C(C=C1)C=CC(=O)O2)CC=O | ||
| TCMBANKIN008942 | meranzin | MCULE-6120837821; 489-53-2; Merangin; (R)-Meranzin; CHEMBL52267; 8-[(3,3-dimethyloxiran-2-yl)methyl]-7-methoxychromen-2-one; 2H-1-Benzopyran-2-one,8-[(3,3-dimethyl-2-oxiranyl)methyl]-7-methoxy-; AC1MXPBD; NP106; MolPort-002-509-445; ACM489532; AKOS030488681; STOCK1N-03926; BG00613907; 8-[(3,3-dimethyloxiran-2-yl)methyl]-7-methoxy-2H-chromen-2-one | C15H16O4 | 260.28 g/mol | CC1(C(O1)CC2=C(C=CC3=C2OC(=O)C=C3)OC)C |
| TCMBANKIN009280 | 7-niethojcy-8-(3-methyl-2-oxobut-3en-l-y丨)-2H-chromen-2-one | ||||
| TCMBANKIN009919 | mexolide | C32H32O8 | 544.6 g/mol | CC1=CC(C(CC1)(C)C=CC2=C(C=C(C3=C2OC(=O)C=C3)OC)OC)C4=C(C=C(C5=C4OC(=O)C=C5)OC)OC | |
| TCMBANKIN010256 | murrayacine | C18H15NO2 | 277.3 g/mol | CC1(C=CC2=C(O1)C(=CC3=C2NC4=CC=CC=C43)C=O)C | |
| TCMBANKIN014212 | α- Cubeb oleyl | ||||
| TCMBANKIN014453 | Bicyclo [4.4.0] dodeca-1-ene | ||||
| TCMBANKIN015968 | minwanensin | C15H24O5 | 284.35 g/mol | CC1CC(C2(C13CC(C(C2(C)CO)C)OC(=O)C3)O)O | |
| TCMBANKIN016395 | 3, 3',4',5,5',6,7, 8-Octamethoxyflavone | ||||
| TCMBANKIN016977 | 5-Hydroxy-3,3',4',5',7-pentamethoxyflavone | C20H20O8 | 388.4 g/mol | COC1=CC(=C2C(=C1)OC(=C(C2=O)OC)C3=CC(=C(C(=C3)OC)OC)OC)O | |
| TCMBANKIN017431 | mahanimbinine | C23H27NO2 | 349.5 g/mol | CC1=CC2=C(C3=C1OC(C=C3)(C)CCCC(C)(C)O)NC4=CC=CC=C42 | |
| TCMBANKIN018102 | isolongifolene | C15H24 | 204.35 g/mol | CC1(CCC=C2C13CCC(C3)C2(C)C)C | |
| TCMBANKIN020191 | murrayatin | C20H26O6 | 362.4 g/mol | CC(C)CC(=O)OC(CC1=C(C=CC2=C1OC(=O)C=C2)OC)C(C)(C)O | |
| TCMBANKIN021396 | mahanimbidine | C23H25NO | 331.4 g/mol | CC1=CC2=C3C4=C1OC5(CCC(C4C5)C(N3C6=CC=CC=C62)(C)C)C | |
| TCMBANKIN023602 | (+)-mahanimbine | C23H25NO | 331.4 g/mol | CC1=CC2=C(C3=C1OC(C=C3)(C)CCC=C(C)C)NC4=CC=CC=C42 | |
| TCMBANKIN024091 | 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,8-dimethoxy-chromone | 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,8-dimethoxy-chromen-4-one; 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,8-dimethoxychromen-4-one; 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,8-dimethoxy-4-chromenone | 376.34 | ||
| TCMBANKIN024162 | osthol eposide | ||||
| TCMBANKIN024902 | 2-methyl-5-(1-methylethyl)- bicyclo [3.1.0]-2-hexene | ||||
| TCMBANKIN025243 | Incense tree ene | ||||
| TCMBANKIN025557 | (+)-(1S, 3S)a mint. 4,8. Diene | ||||
| TCMBANKIN026634 | 7-methoxy-8-[(I'R , 2'R )]-1-hydroxy-2-methoxy-3-niethylbut-3en-l-yl]-2H-chromen-2-one | ||||
| TCMBANKIN027284 | murraxonin | C13H12O4 | CC(=O)C=CC1=CC2=C(C=C1)OC(=C2OC)O | ||
| TCMBANKIN028194 | 7-methoxy-8-(2'-methoxy-3'-hydroxy-3’-methyl-butyl)coumarin | C16H20O5 | CC(C)(C(CC1=C(C=C2C(=C1)C=CC(=O)O2)OC)OC)O | ||
| TCMBANKIN028659 | sodium danshensu | C9H10NaO5 | 221.16 g/mol | C1=CC(=C(C=C1CC(C(=O)O)O)O)O.[Na] | |
| TCMBANKIN028742 | 3,3,4' ,5.5', 6,6',7,8-Octamethoxyflavone | ||||
| TCMBANKIN029258 | Pakistan can β- ethylenically | C9H14ClNO2 | CNCC(C1=CC(=CC=C1)O)O.Cl | ||
| TCMBANKIN030805 | Cis-dehydroosthol | C15H14O3 | 242.27 g/mol | CC(=C)C=CC1=C(C=CC2=C1OC(=O)C=C2)OC | |
| TCMBANKIN031163 | 7-methoxy-8-[(1'R,2'R)]-l-hydroxy-2-methoxy-3-methy 1 but-3en-l-yl]-2H-chromen-2-one | ||||
| TCMBANKIN033080 | Ylang oil ene | ||||
| TCMBANKIN033636 | γ-terpene | ||||
| TCMBANKIN033678 | caffeine | NCGC00015208-02; DHCplus; KBio2_001781; W222402_ALDRICH; NINDS_000730; EINECS 200-362-1; Spectrum5_000423; BSPBio_001921; KBio1_000730; ACon1_000085; Probes1_000150; Quick-Pep; D00528; AIDS001649; WLN: T56 BN DN FNVNVJ B1 F1 H1; 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione; SK 65 Compound; NCGC00090699-07; KBio2_006917; Stim; Caffeina [Italian]; 1,3,7-trimethylpurine-2,6-dione; PDSP2_001219; C7731_SIAL; KBioSS_001781; Caffein; Miudol; Nix Nap; nchembio774-comp2; Nodaca; Caffeine (natural); Cafeina; CFF; Caffeine solution; 7-methyltheophylline; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein); Bio1_000962; TNP00310; 75035_FLUKA; 1,3,7-Trimethyl-2,6-dioxopurine; NCGC00090699-08; Caffeine, anhydrous; Koffein [German]; C1778_SIAL; Dexitac; 3,7-dihydro-1,3,7-trimethyl-1H-purine; 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Durvitan; PDSP2_001000; MLS001066409; Eldiatric C; SPECTRUM1500155; cafeine; Koffein; NCIOpen2_008255; BRN 0017705; 71701-02-5; C8960_SIAL; Bio1_001451; MLS001056714; Caffeine (USP); caffenium; SPBio_001222; 27602_FLUKA; 95789-13-2; Spectrum3_000321; Cafecon; Thein; NCGC00015208-01; Coffeinum; 1-methyltheobromine; Mettler Toledo Calibration substance ME 18872, Caffeine; Kofein [Czech]; NSC 5036; Spectrum_001301; NCGC00090699-04; Bayer Select Headache Pain; Theine; Guaranine; KBio3_001141; NSC5036; 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine; Spectrum2_001261; EU-0100228; Probes2_000128; MEGxp0_001350; Anhydrous caffeine (TN); 1,3,7-Trimethylxanthine; 58-08-2; Caffedrine; C07481; No-Doz; PDSP1_001016; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; InChI=1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H; Phensal; Refresh'n; KBio2_004349; AIDS-001649; Tri-Aqua; Lopac0_000228; ZINC00001084; teina; Methyltheobromine; IDI1_000730; Caffeine, synthetic; 5-26-13-00558 (Beilstein); LS-187843; Theophylline Me; 5-26-13-00558 (Beilstein Handbook Reference); Coffein [German]; C6035_SIGMA; HSDB 36; DivK1c_000730; SDCCGMLS-0064595.P001; KBioGR_002325; NCI-C02733; SBB006474; Spectrum4_001782; Coffeine; Anhydrous caffeine; SMR000326667; 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-; Theobromine, 1-methyl-; Theophylline, 7-methyl; MolMap_000054; NCGC00090699-01; Theobromine Me; LS-237; Cafamil; Cafipel; c1094; AI3-20154; SDCCGMLS-0064595.P002; Xanthine, 1,3,7-trimethyl; Bio1_000473; Mateina; Methylxanthine theophylline; FEMA No. 2224; CHEBI:27732; Tirend; component of P-A-C Compound; Caffeine; Organex; NCGC00090699-03; component of Cafergot; CCRIS 1314; Methyltheobromide; Lopac-C-0750; 3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI); Alert-Pep; C0750_SIAL; PDSP1_001235; Anhydrous caffeine (JP15); Vivarin; Caffeine [BAN:JAN]; Coffein; Caffine | C8H10N4O2 | 194.19 | CN1C=NC2=C1C(=O)N(C(=O)N2C)C |
| TCMBANKIN033813 | 1,6-diene ring Gyu | ||||
| TCMBANKIN034267 | murrangatin acetate | C17H20O6 | CC(C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)O)OC(=O)C | ||
| TCMBANKIN035110 | phebalosin | 7-methoxy-8-(3-prop-1-en-2-yloxiran-2-yl)chromen-2-one; AC1NSZK9; MolPort-005-945-718; MLS004491682; MCULE-8031040658; DG261A2; SCHEMBL14315516; 8-(3-isopropenyloxiran-2-yl)-7-methoxy-chromen-2-one; AK-693/41507039; NCGC00385172-01!7-methoxy-8-(3-prop-1-en-2-yloxiran-2-yl)chromen-2-one; phebalosin ; 7-Methoxy-8-(3-isopropenyloxiranyl)-2H-1-benzopyran-2-one; SMR003288649 | C15H14O4 | 258.27 g/mol | CC(=C)C1C(O1)C2=C(C=CC3=C2OC(=O)C=C3)OC |
| TCMBANKIN035152 | murracarpin | C16H18O5 | 290.31 g/mol | CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC)O | |
| TCMBANKIN035798 | murrayone | C15H14O4 | 258.27 g/mol | CC(=C)C(=O)CC1=C(C=CC2=C1OC(=O)C=C2)OC | |
| TCMBANKIN036274 | bisabolene | Cyclohexene, 4-(1,5-dimethyl-4-hexen-1-ylidene)-1-methyl-; Bisabolene; 495-62-5; Cyclohexene, 4-(1,5-dimethyl-4-hexenylidene)-1-methyl-, (Z)-; 4-(1,5-Dimethyl-4-hexenylidene)-1-methylcyclohexene; UNII-E452K502K0; 2-Heptene, 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-, (Z)-; 6-Methyl-2-(4-methylcyclohex-3-enyl)hept-1,5-diene; 2-Heptene, 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)- (7CI,8CI); Bisabolene (6CI); 2-Heptene, 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-; (1Z)-bisabola-1(10),4,7(11)-triene; 2-methyl-6-(4-methylcyclohex-3-enylidene)hept-2-ene; (4Z)-1-methyl-4-(6-methylhept-5-en-2-ylidene)cyclohexene; 1-Methyl-4-(1,5-dimethyl-4-hexenylidene)-1-cyclohexene; gamma-Bisabolen; (Z)-gamma-bisabolene; I14-60981; 1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene; Cyclohexene, 4-(1,5-dimethyl-4-hexenylidene)-1-methyl-, (4Z)-; (Z)-.gamma.-Bisabolene; gamma-Bisabolene, (Z)-; FEMA No. 3331; LS-2584; LMPR0103060004; ST098717; EINECS 207-805-8; CHEBI:49238; bisabola-1(10),4,7(11)-triene; E452K502K0; Bisabolene (natural); 2-Methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-2-heptene; (1Z)-bisabola-1(10),4,7(11)-triene (4Z)-4-(1,5-dimethylhex-4-en-1-ylidene)-1-methylcyclohexene; gamma-Bisabolene; XBGUIVFBMBVUEG-CCEZHUSRSA-N; ZINC30731544; Cyclohexene, 4-(1,5-dimethyl-4-hexen-1-ylidene)-1-methyl-, (4Z)-; (Z) gamma-bisabolene; C16814; (4Z)-4-(1,5-dimethylhex-4-en-1-ylidene)-1-methylcyclohexene; AKOS024287123; UNII-E6941S3U3Q component XBGUIVFBMBVUEG-CCEZHUSRSA-N; 11003-31-9; Limene; cis-gamma-Bisabolene; 13062-00-5; CHEBI:49237; (Z)-1-Methyl-4-(6-methylhept-5-en-2-ylidene)cyclohex-1-ene; ST50407046; 4-(1,5-dimethylhex-4-en-1-ylidene)-1-methylcyclohexene; AC1MHWGM; gamma-Bisabolene, (4Z)- | C15H24 | 204.35 g/mol | CC1=CCC(=C(C)CCC=C(C)C)CC1 |
| TCMBANKIN037189 | peroxyauraptenol | C15H16O5 | CC(=C)C(CC1=C(C=CC2=C1OC(=O)C=C2)OC)OO | ||
| TCMBANKIN037345 | murrangatin | C15H16O5 | 276.28 g/mol | CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)O)O | |
| TCMBANKIN037670 | isomurranganone senecioate | C20H22O6 | |||
| TCMBANKIN037951 | 3,5,6,7,3',4'-hexamethoxyflavone | C21H22O8 | 402.4 g/mol | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC)OC)OC | |
| TCMBANKIN041411 | Murralongin | 258.27 g/mol | |||
| TCMBANKIN042054 | mahuangnin a | C30H24O10 | 544.506 | ||
| TCMBANKIN042100 | auraptenol | C15H16O4 | 260.285 | O1c(c(C([H])([H])[C@@]([H])(C(=C([H])[H])C([H])([H])[H])O[H])c(OC([H])([H])[H])c([H])c2[H])c2C([H])=C([H])C1=O | |
| TCMBANKIN043839 | peroxymurraol | C15H16O5 | |||
| TCMBANKIN046191 | isomurralonginol acetate | C17H18O5 | 302.32 g/mol | CC(=C)C(COC(=O)C)C1=C(C=CC2=C1OC(=O)C=C2)OC | |
| TCMBANKIN046249 | camphene | CHEMBL506889; CJ-04639; (-)-camphene; (-)-Camphene, technical grade, 75% (90% as camphene and fenchene); L-Camphene; DSSTox_RID_81702; (1S,4R)-2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S)-; (1S)-2,2-Dimethyl-3-methylenebicyclo(2.2.1)heptane; DSSTox_CID_26538; FCH1121419; (1S,4R)-2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane; 5794/4/7; C06305; (-) camphene; ZB015525; CC-00037; M5YAV509FN; UNII-G3VG94Z26E component CRPUJAZIXJMDBK-BDAKNGLRSA-N; DTXSID3046538; ZINC968230; CHEBI:89; (1S,4R)-camphene; (-)-Comphene; cam phene; DSSTox_GSID_46538; NCGC00166100-01; (-)-(1S,4R)-camphene; Bicyclo(2.2.1)heptane, 2,2-dimethyl-3-methylene-, (1S,4R)-; CAS-5794-04-7; EINECS 227-337-8; UNII-M5YAV509FN; CRPUJAZIXJMDBK-BDAKNGLRSA-N; (1S)-2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane; Tox21_112314 | C10H16 | 136.23 g/mol | CC1(C2CCC(C2)C1=C)C |
| TCMBANKIN058114 | trans-caffeic acid | 3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid | C9H8O4 | 180.16 g/mol | C1=CC(=C(C=C1C=CC(=O)O)O)O |
| TCMBANKIN058411 | napthalene | Caswell No. 587; Naphthalene (molten); 91-20-3; NPY; 8,8-dimethyl-7,8-dihydropyrano[3,2-g]chromene-2,6-dione; 6,7-Dihydro-8,8-dimethyl-2h,8h-benzo(1,2-b:5,4-b')dipyran-2,6-dione; WEDGVCZUPFZNDE-UHFFFAOYSA-N; WLN: L66J; 8,8-Dimethyl-7,8-dihydro-2H,6H-pyrano[3,2-g]chromene-2,6-dione #; Naphthene; 48641_SUPELCO; 8,8-Dimethyl-7,8-dihydro-pyrano[3,2-g]chromene-2,6-dione; 13,13-DIMETHYL-4,14-DIOXATRICYCLO[8.4.0.0(3),?]TETRADECA-1,3(8),6,9-TETRAENE-5,11-DIONE; DTXSID10167830; NAPHTHALENE; HSDB 184; InChI=1/C14H12O4/c1-14(2)7-10(15)9-5-8-3-4-13(16)17-11(8)6-12(9)18-14/h3-6H,7H2,1-2H; nchembio791-comp1; Albocarbon; CHEBI:16482; NCI-C52904; 84679_FLUKA; NCGC00090793-01; Naftalen [Polish]; Naphthalene-UL-14C; Di(C5-C6)alkylnaphthalene; Naphthalene, di-C5-6-alkyl derivs.; Dezodorator; CCRIS 1838; NSC 37565; Naphtalene [ISO:French]; White tar; InChI=1/C10H8/c1-2-6-10-8-4-3-7-9(10)5-1/h1-8; 8,8-dimethyl-2H,6H,7H,8H-pyrano[3,2-g]chromene-2,6-dione; 6,7-Dihydro-8,8-dimethyl-2H,8H-benzo[1,2-b:5,4-b']dipyran-2,6-dione; c0333; N3145_SIGMA; AI3-00278; 2,2-dimethyl-3H-pyrano[5,6-g]chromene-4,8-quinone; Moth balls; Naphthalene solution; NCGC00090793-02; NSC37565; Mighty RD1; Camphor tar; Mothballs; 16499-05-1; 40053_SUPELCO; 8,8-dimethyl-7,8-dihydropyrano[3,2-g]chromen-2,6-dione; Naphthaline; Naphthalene, crude or refined; Tar camphor; UN1334; Naphthalene, molten; 2H,6H-Benzo[1,2-b:5,4-b']dipyran-2,6-dione, 7,8-dihydro-8,8-dimethyl-; EINECS 202-049-5; Moth flakes; RCRA waste no. U165; Graveolone; NAPHTHALENE-RING; 48546_SUPELCO; AC1L42XS; Naphthalene, crude or refined [UN1334] [Flammable solid]; EPA Pesticide Chemical Code 055801; 8,8-Dimethyl-7,8-dihydro-2H,6H-pyrano[3,2-g]chromene-2,6-dione; UN2304; 147141_ALDRICH; Naphthalene [BSI:ISO]; RCRA waste number U165; Naphthalene, molten [UN2304] [Flammable solid]; Naftalen; CTK8H1786; 2,2-dimethyl-3H-pyrano[3,2-g]chromene-4,8-dione; NAPHTHYL GROUP; C00829; naphtalene; Mighty 150; 72931-45-4; 8,8-DIMETHYL-7H-PYRANO[3,2-G]CHROMENE-2,6-DIONE; N7394_SIGMA; Naphthalin; 6,7-Dihydro-8,8-dimethyl-2H,8H-benzo-(1,2b:5,4')-dipyran-2,6-dione; 184500_ALDRICH; Naphthalene, pure; 68412-25-9 | C10H8 | 128.17 g/mol | C1=CC=C2C=CC=CC2=C1 |
| TCMBANKIN058612 | Zyklohexen | CHEBI:36404; 7493-04-1; 110-83-8; 3,4,5,6-Tetrahydrobenzene; 83224-EP2274983A1; 83224-EP2270114A1; 195642-EP2277872A1; 91500-EP2295429A1; 195642-EP2272972A1; Cyclohexene-3-ylradical; cyclohex-2-enyl; 91500-EP2284157A1; 195642-EP2272973A1; Cyclohexene; 83224-EP2292596A2; 1-cyclohex-2-enyl; 2-cyclohexenyl; 91500-EP2305668A1; 83224-EP2305655A2; cyclohexene; InChI=1/C6H10/c1-2-4-6-5-3-1/h1-2H,3-6H; Cyclohexene; Tetrahydrobenzene; Cyclohexene [UN2256] [Flammable liquid]; 3-Cyclohexenyl radical; Benzenetetrahydride; WLN: L6UTJ; 1,2,3,4-Tetrahydrobenzene; 125431_ALDRICH; UN2256; Benzene, tetrahydro-; 4-Cyclohexenyl radical; 33004-06-7; 1-cyclohexene; Cykloheksen [Polish]; EINECS 203-807-8; NSC 24835; 4-05-00-00218 (Beilstein Handbook Reference); AI3-03146; Hexanaphthylene; 15650-80-3; Benzene tetrahydride; Cyclohex-1-ene; BRN 0906737; NSC24835; Cykloheksen; HSDB 1624; 44028_FLUKA | C6H10 | 82.14 g/mol | C1CCC=CC1 |
| TCMBANKIN058676 | threo-murrangatin | minumicrolin; murpanidin(s); erythro-murrangatin; murrangatin; (s)-murpanidin | C15H16O5 | 276.28 g/mol | CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)O)O |
| TCMBANKIN058677 | albiflorin-2 | albiflorin-3; murracarpin | C16H18O5 | 290.31 g/mol | CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC)O |
| TCMBANKIN059080 | mexoticin | isomexoticin | C16H20O6 | 308.33 g/mol | CC(C)(C(CC1=C(C=C(C2=C1OC(=O)C=C2)OC)OC)O)O |
| TCMBANKIN059096 | murraonl | murraol | C15H16O4 | 260.28 g/mol | CC(C)(C=CC1=C(C=CC2=C1OC(=O)C=C2)OC)O |
| TCMBANKIN059128 | murranganon | (±)-murpaniculol;murpaniculol;(+)-murranganone | C15H16O5 | CC(C)C(=O)C(C1=C(C=CC2=C1OC(=O)C=C2)OC)O | |
| TCMBANKIN059130 | Isomeranzin | AIDS-080545; 7-methoxy-8-(3-methyl-2-oxobutyl)chromen-2-one; 7-methoxy-8-(3-methyl-2-oxo-butyl)chromen-2-one; isomeranzin; Isomeramazin; 2H-1-Benzopyran-2-one, 7-methoxy, 8-(2-oxoisopentyl); AIDS080545; 7-methoxy-8-(3-methyl-2-oxobutyl)-2-chromenone; 7-Methoxy-8-(3-methyl-2-oxobutyl)-2H-chromen-2-one; 8-(2-keto-3-methyl-butyl)-7-methoxy-coumarin;isomeranzine | C15H16O4 | 260.29 | CC(C)C(=O)CC1=C(C=CC2=C1OC(=O)C=C2)OC |
| TCMBANKIN059217 | beta-Bourbonene | (-)-beta-Bourbonene;beta .-Bourbonene;(-)-β-Bour-bonene; Bourbonene, beta-; Cyclobuta(1,2:3,4)dicyclopentene, decahydro-3a-methyl-6-methylene-1-(1-methylethyl)-, (1S-(1alpha,3aalpha,3bbeta,6abeta,6balpha))-; β-bourbonene; Decahydroisopropylmethylmethylenecyclobuta(1,2:3,4)dicyclopentene; beta-bourbonene; 1,2,3,3a,3bbeta,4,5,6,6abeta,6balpha-decahydro-1alpha-isopropyl-3aalpha-methyl-6-methylenecyclobuta(1,2:3,4)dicyclopentene; Decahydro-3a-methyl-6-methylene-1-(1-methylethyl)cyclobuta(1,2:3,4)dicyclopentene, (1S-(1alpha,3aalpha,3bbeta,6abeta,6balpha))-; beta- Bourbonene; 13833-27-7; β- Bourbon ene; Cyclobuta(1,2:3,4)dicyclopentene, 1,2,3,3a,3bbeta,4,5,6,6abeta,6balpha-decahydro-1alpha-isopropyl-3aalpha-methyl-6-methylene | C15H24 | 204.35 | CC(C)C1CCC2(C1C3C2CCC3=C)C |
| TCMBANKIN059527 | (+)-Camphene | C10H16 | 136.23 g/mol | CC1(C2CCC(C2)C1=C)C | |
| TCMBANKIN059946 | isomahanimbine | C23H25NO | 331.4 g/mol | CC1=CC2=C(C=C1)NC3=C2C=CC4=C3C=CC(O4)(C)CCC=C(C)C | |
| TCMBANKIN059974 | alpha-phellandrene | C10H16 | 136.23 | CC1=CCC(C=C1)C(C)C | |
| TCMBANKIN059976 | humulene | C15H24 | 204.35 g/mol | CC1=CCC(C=CCC(=CCC1)C)(C)C | |
| TCMBANKIN060015 | 9-epi-(E)-caryophyllene | C15H24 | 204.35 g/mol | CC1=CCCC(=C)C2CC(C2CC1)(C)C | |
| TCMBANKIN060593 | ()-Aromadendrene;(+)-aromadendrene | C15H24 | 204.35 | CC1CCC2C1C3C(C3(C)C)CCC2=C | |
| TCMBANKIN061044 | Pentadecanoate | C15H29O2- | 241.39 g/mol | CCCCCCCCCCCCCCC(=O)[O-] | |
| TCMBANKIN061262 | 7-Methoxy-8-(2'-ethoxy-3'-hydroxy-3'-methybutyl)coumarin | C17H22O5 | 306.39 | CCOC(C)(C)C(CC1=C(C=CC2=C1OC(=O)C=C2)OC)O | |
| TCMBANKIN061266 | murraxocin | C17H20O5 | 304.34 g/mol | CCOC(C1=C(C=CC2=C1OC(=O)C=C2)OC)C(C(=C)C)O | |
| TCMBANKIN061528 | scopoletin | NINDS_000720; 7-hydroxy-6-methoxy-coumarin; NCGC00016349-05; 6-methoxy-7-hydroxycoumarin; 6-methoxy-7-oxidanyl-chromen-2-one; CHEBI:17488; SPBio_002884; HMS1571A05; RODXRVNMMDRFIK-UHFFFAOYSA-N; NCGC00016349-08; TR-029034; 5-18-03-00203 (Beilstein Handbook Reference); Acid, Gelseminic; 6-Methylesculetin; UNII-KLF1HS0SXJ; 7-hydroxy 6-methoxy coumarine; Scopoletin, >=99%; AB00443525; beta -methylesculetin; CS-5791; BRN 0156296; NCGC00094973-02; SR-01000841273-4; HMS2268G04; SCHEMBL147702; scopoletin ; Prestwick3_000962; CHEMBL71851; Escopoletin; Spectrum2_001207; HMS2098A05; NCGC00016349-07; NCGC00094973-03; Murrayetin; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; Bio-0208; NCGC00016349-02; Prestwick2_000962; ZB002243; BG01509594; NCGC00016349-03; BPBio1_001061; Scopoletin, analytical standard; AX8035441; 0B4B9FAA-686D-4977-AA08-65F8E4F1977C; BRD-K96163925-001-06-5; ZX-AN021883; FCH1115349; AC1NQX27; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; DTXSID0075368; 7-Hydroxy-5-methoxycoumarin; SC-90283; ST24045669; b-Methylaesculetin; KBioGR_001348; 7-Hydroxy-6-methoxy-2H-chromen-2-one #; Gelseminic acid; ZX-AFC000681; S0367; MLS002154074; 4CN-0905; 6-O-Methylesculetin; HMS502D22; KLF1HS0SXJ; MCULE-6077230919; MLS002472878; IDI1_000720; SPECTRUM1502242; Aesculetin 6-methyl ether; C-30831; MFCD00006872; Scopoletol; Buxuletin; AB0019688; CC-34387; Chrysotropic Acid; RTR-029034; ACon1_000143; CCRIS 3592; 6-Methoxyumbelliferone; LS-55217; NSC-405647; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; BDBM50156693; ZX-AT021192; AK111291; Scopoletin, United States Pharmacopeia (USP) Reference Standard; 7-Hydroxy-6-methoxy-2H-chromen-2-one; I14-14171; Prestwick1_000962; PubChem15777; MolPort-000-707-493; DivK1c_000720; A844290; AN-42608; NCGC00016349-04; ST056287; ZINC57733; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Acid, Chrysotropic; NSC405647; SR-01000841273; Prestwick0_000962; BSPBio_000963; KBio1_000720; FT-0631451; beta-Methylesculetin; Spectrum4_001054; SR-01000841273-3; AJ-09778; 7-Hydroxy-6-methoxycoumarin; W-3522; MEGxp0_001192; HY-N0342; NCGC00016349-06; Scopoletine; 7-hydroxy-6-methoxy-1-benzopyran-2-one; 006S872; OR22352; S-2000; NCGC00094973-01; EINECS 202-171-9; TNP00096; KS-00000YGS; Spectrum5_000654; Spectrum3_001532; TD8126; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); SPBio_000994; AKOS000277133; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; SMR000112541; BIDD:PXR0125; CCG-39140; Esculetin 6-methyl ether; D05QOR; 92-61-5; ALBB-023369; 7-hydroxy-6-methoxychromen-2-one; C01752; BIS1402; HMS1921N16; KB-249948; .beta.-Methylesculetin; NCGC00016349-01; Baogongteng B; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; NINDS_000720; 7-Hydroxy-5-methoxycoumarin; 7-hydroxy-6-methoxy-coumarin; Scopoletine; S2500_SIGMA; 7-hydroxy-6-methoxy-2H-chromen-2-one; CHEBI:17488; KBioGR_001348; SPBio_002884; Prestwick1_000962; NCGC00094973-01; 5-18-03-00203 (Beilstein Handbook Reference); EINECS 202-171-9; scopoletol; TNP00096; AIDS-014975; Gelseminic acid; DivK1c_000720; 6-O-Methylesculetin; Spectrum5_000654; Spectrum3_001532; 6-Methylesculetin; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); MEGxp0_001192; SPBio_000994; Scopoletin; 84792_FLUKA; IDI1_000720; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; ST056287; NCGC00094973-02; BRN 0156296; SPECTRUM1502242; Esculetin 6-methyl ether; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Prestwick3_000962; 7-hydroxy-6-methoxy-2-chromenone; Escopoletin; Spectrum2_001207; NCGC00094973-03; Murrayetin; 92-61-5; NSC405647; BSPBio_000963; NCGC00016349-02; KBio1_000720; 7-hydroxy-6-methoxychromen-2-one; Prestwick0_000962; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; C01752; ZINC00057733; AIDS014975; Prestwick2_000962; Spectrum4_001054; beta-Methylesculetin; ACon1_000143; BPBio1_001061; CCRIS 3592; 6-Methoxyumbelliferone; 7-Hydroxy-6-methoxycoumarin; .beta.-Methylesculetin; NCGC00016349-01; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; 6-methoxy-7-hydroxycoumarin; 7- hydroxy- 6-methoxy- coumarin; 6-methoxy-7-hydroxy coumarin; Scopoletol | C10H8O4 | 192.17 g/mol | COC1=C(C=C2C(=C1)C=CC(=O)O2)O |
| TCMBANKIN061929 | 1-methoxy-2-methoxymethyl-3-hydroxy-anthraquinone | C17H14O5 | COCC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab